TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 93 filers reported holding TCR2 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $48 | +50.0% | 31,720 | -0.6% | 0.03% | +55.6% |
Q4 2022 | $32 | -99.9% | 31,919 | 0.0% | 0.02% | -50.0% |
Q3 2022 | $57,000 | -38.7% | 31,919 | 0.0% | 0.04% | -35.7% |
Q2 2022 | $93,000 | +5.7% | 31,919 | -0.3% | 0.06% | +21.7% |
Q1 2022 | $88,000 | -40.9% | 32,003 | 0.0% | 0.05% | -38.7% |
Q4 2021 | $149,000 | -45.2% | 32,003 | 0.0% | 0.08% | -46.8% |
Q3 2021 | $272,000 | -53.7% | 32,003 | -10.5% | 0.14% | -49.5% |
Q2 2021 | $587,000 | -25.7% | 35,758 | 0.0% | 0.28% | -23.6% |
Q1 2021 | $790,000 | -21.0% | 35,758 | +10.6% | 0.36% | -32.4% |
Q4 2020 | $1,000,000 | – | 32,342 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |